As of 4:00pm ET
| -0.92 / -1.13%|
The 9 analysts offering 12-month price forecasts for China Biologic Products Holdings Inc have a median target of 102.00, with a high estimate of 132.00 and a low estimate of 89.40. The median estimate represents a +26.79% increase from the last price of 80.45.
The current consensus among 9 polled investment analysts is to Buy stock in China Biologic Products Holdings Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.